Coyote Bioscience Co., Ltd.
PrivateLast Round
Series D
Dec 23, 2020
Total Funding Raised
$108.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Coyote Bioscience Co., Ltd. operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series D round in December 2020.
Coyote Bioscience Co., Ltd. is a biotechnology company that develops point-of-care testing (POCT) solutions and fully automated, integrated rapid molecular diagnostic systems.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Coyote Bioscience Co., Ltd. Comparables
Compare Coyote Bioscience Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Credo Diagnostics Biomedical | 86% | |
| Hangzhou LifeReal Biotechnology | 85% | |
| Igenesis | 83% |
For institutional investors. Book with your work email.
Coyote Bioscience Co., Ltd. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Coyote Bioscience Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Legend Star | Series B |
| Hillhouse Investment | Series D |
| Northern Light Venture Capital | Series B |
| SAIF Partners | Series B |
| Elevation Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 114% MoM, reaching 19.9K.
- Jul 26, 2026
Monthly visitors increased 3040% MoM, reaching 9.3K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingNov 12, 2026
Coyote Bioscience Co. works with BioMap on an "AI + Biology" initiative that combines research translation across industry, academia, and research institutions with an open cartridge ecosystem to support collaboration on molecular point-of-care testing in Hong Kong.
For institutional investors. Book with your work email.
Coyote Bioscience Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Coyote Bioscience Co., Ltd.'s valuation, stock price, and market status.
Is Coyote Bioscience Co., Ltd. a public or private company?
Coyote Bioscience Co., Ltd. is a private company.
What is the current stock price of Coyote Bioscience Co., Ltd.?
Coyote Bioscience Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Coyote Bioscience Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Coyote Bioscience Co., Ltd. worth (valuation)?
Valuation information for Coyote Bioscience Co., Ltd. is not publicly available.
Can I buy Coyote Bioscience Co., Ltd. stock?
Coyote Bioscience Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Coyote Bioscience Co., Ltd.'s last funding round?
Coyote Bioscience Co., Ltd.'s most recent funding round was Series D on December 23, 2020.
Who are the main investors in Coyote Bioscience Co., Ltd.?
Key investors in Coyote Bioscience Co., Ltd. include Northern Light Venture Capital, Elevation Capital.
Will Coyote Bioscience Co., Ltd. IPO soon?
No public IPO plans have been announced for Coyote Bioscience Co., Ltd..
How can I track Coyote Bioscience Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Coyote Bioscience Co., Ltd.'s shares on secondary markets.